Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy

Last modified: October 22, 2020
You are here:
Estimated reading time: 1 min
Research Article: Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy
Author: Weerachai Chaijamorn, Dhakrit Rungkitwattanakul, Nantana Nuchtavorn, Taniya Charoensareerat, Sutthiporn Pattharachayakul, Wiriyaporn Sirikun, Nattachai Srisawat
Email: Weerachai.Cha@siam.edu
Department/Faculty Faculty of Pharmacy,  Siam University, Bangkok 10160
Published: Critical Care Explorations: October 01, 2020 – Volume 2 – Issue 10 – p e0242
doi: 10.1097/CCE.0000000000000242

Citation

Weerachai Chaijamorn, Dhakrit Rungkitwattanakul, Nantana Nuchtavorn, Taniya Charoensareerat, Sutthiporn Pattharachayakul, Wiriyaporn Sirikun, Nattachai Srisawat. (2020). Antiviral dosing modification for Coronavirus Disease 2019 – Infected patients receiving extracorporeal therapy. Critical Care Explorations. 2(10),  e0242.


ABSTRACT

Previous literature regarding coronavirus disease 2019 outlined a presence of organ dysfunction including acute respiratory distress syndrome and acute kidney injury that are linked to mortality. Several patients require extracorporeal therapy. This review aims to gather available published resources including physicochemical and pharmacokinetic properties and suggests antiviral drug dosing adaptation for coronavirus disease 2019–infected critically ill patients receiving extracorporeal therapy. A literature search was performed using PubMed, clinical trial registries, and bibliographic review of textbooks and review articles. Unfortunately, no standard of pharmacologic management and recommendations of drug dosing for coronavirus disease 2019 infection for critically ill patients receiving extracorporeal therapy exist due to the limited data on pharmacokinetics and clinical studies. All available extracted data were analyzed to suggest the appropriate drug dosing adjustment. Antiviral drug dosing adjustments for critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy are presented in this review. Considering pathophysiologic changes, drug properties, and extracorporeal modalities, applying our suggestion is recommended.

 

Key Words: antivirals, continuous renal replacement therapy, coronavirus disease 2019, extracorporeal membrane oxygenation, extracorporeal therapy.


Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy

Faculty of Pharmacy, Siam University, Bangkok, Thailand

Related

Tags:
Was this article helpful?
Dislike 0
Views: 39